Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function
- PMID: 27567887
- DOI: 10.3233/JPD-160874
Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function
Abstract
Background: Scans without evidence of dopaminergic deficit (SWEDD), a heterogeneous disorder, refers to patients with normal dopamine transporter scan presumed to have Parkinson's disease (PD). Although clinically hard to discriminate, it is important to differentiate SWEDD from PD in the early stage of disease in practice. Olfactory dysfunction is a sensitive biomarker of neurodegeneration. A considerable number of SWEDD patients show abnormal olfaction. We investigated the olfaction and non-motor symptoms in SWEDD, PD, and healthy controls. A subgroup analysis of SWEDD by olfactory function was also conducted.
Methods: This study enrolled 40 SWEDD, 28 PD, and 26 healthy controls. The Korean version of Sniffin's stick test II (KVSS II) and the Korean version of non-motor symptoms scale for PD (K-NMSS) were used to evaluate olfaction and non-motor symptoms. Patients with SWEDD were categorized into normal olfaction (SWEDD-N) and olfactory dysfunction (SWEDD-D) subgroups.
Results: Overall KVSS II scores of SWEDD group was distinctive when compared to those of PD or controls. K-NMSS scores were increased in PD compared to those in SWEDD or controls. In subgroup analysis, KVSS II scores in SWEDD-D were similar to those in PD. K-NMSS scores in SWEDD-D were also significantly higher than those in SWEDD-N but lower than those in PD.
Conclusions: Olfactory dysfunction could be a biomarker to differentiate SWEDD from PD. Non-motor symptoms differed between the two SWEDD subgroups classified by olfaction. These findings suggest that the underlying pathophysiology of SWEDD with normal olfaction and olfactory dysfunction might be different.
Keywords: Parkinson’s disease; SWEDD; non-motor symptoms; olfaction.
Similar articles
-
Microstructural patterns in substantia nigra subregions are associated with depression and olfactory impairments in Parkinson's disease.Clin Neurol Neurosurg. 2025 Apr;251:108817. doi: 10.1016/j.clineuro.2025.108817. Epub 2025 Mar 8. Clin Neurol Neurosurg. 2025. PMID: 40080943
-
Classification of Parkinson's disease with and without dopaminergic deficiency based on non-motor symptoms and structural neuroimaging.Neurol Sci. 2025 Jun;46(6):2611-2625. doi: 10.1007/s10072-025-08045-6. Epub 2025 Feb 19. Neurol Sci. 2025. PMID: 39969749
-
Distinctive clinical and imaging trajectories in SWEDD and Parkinson's disease patients.Neuroimage Clin. 2024;42:103592. doi: 10.1016/j.nicl.2024.103592. Epub 2024 Mar 14. Neuroimage Clin. 2024. PMID: 38493585 Free PMC article.
-
A clinical approach towards smell loss in Parkinson's disease.J Parkinsons Dis. 2014;4(2):189-95. doi: 10.3233/JPD-130278. J Parkinsons Dis. 2014. PMID: 24322062 Review.
-
Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.Neurosci Bull. 2017 Oct;33(5):515-525. doi: 10.1007/s12264-017-0170-x. Epub 2017 Aug 22. Neurosci Bull. 2017. PMID: 28831680 Free PMC article. Review.
Cited by
-
Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.Front Neurol. 2020 May 29;11:447. doi: 10.3389/fneur.2020.00447. eCollection 2020. Front Neurol. 2020. PMID: 32547477 Free PMC article. Review.
-
Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.Int J Mol Sci. 2021 Oct 18;22(20):11234. doi: 10.3390/ijms222011234. Int J Mol Sci. 2021. PMID: 34681899 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical